Unproven peptide therapies sold in grey market as pharmacies push for legal access
Peptide therapies marketed for longevity and wellness benefits are being sold through an unregulated grey market online, despite lacking proven clinical evidence. Compounding pharmacies are pushing for the legal right to manufacture these substances to meet growing consumer demand. The therapies' safety and legal status remain largely unresolved.
Comments
No comments yet
Comments
No comments yet โ be the first to weigh in ๐
No comments yet. Be the first!